Unknown NA INTERVENTIONAL 1-arm NCT05044169

Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

Efficacy and Safety of Broncho-Vaxom in Reducing Recurrence in Children With Steroid-sensitive Nephrotic Syndrome: Prospective, Randomized Controlled, Multicenter Clinical Study

Sponsor: Fang Deng

Conditions Nephrotic Syndrome in Children

Interventions Broncho-Vaxom

Updated 4 times since 2021 Last updated: Sep 5, 2021 Started: Sep 30, 2021 Primary completion: Sep 30, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05044169, this NA trial focuses on Nephrotic Syndrome in Children and remains ongoing. Sponsored by Fang Deng, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Oct 2021 — Jan 2024 [monthly]

Not Yet Recruiting NA

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fang Deng

Data source: Anhui Provincial Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.